GulecSA, KukerRA, GoryawalaM, FernandezC, PerezR, Khan-GhanyA, ApazaA, HarjaE, HarrellM. 2016. 124I PET/CT in patients with differentiated thyroid cancer: clinical and quantitative image analysis. Thyroid, 26:441–448.
2.
PaciniF, AgateL, EliseiR, CapezzoneM, CeccarelliC, LippiF, MolinaroE, PincheraA. 2001. Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients. J Clin Endocrinol Metab, 86:4092–4097.
3.
CailleuxAF, BaudinE, TravagliJP, RicardM, SchlumbergerM. 2000. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?. J Clin Endocrinol Metab, 85:175–178.
4.
KistJW, de KeizerB, van der VliesM, BrouwersAH, van der ZantFM, HermsenR, HuysmansD, StokkelMPM, HoekstraOS, VogelWV. 2016. 124I PET/CT to predict the outcome of blind 131I treatment in patients with biochemical recurrence of differentiated thyroid cancer; results of a multicenter diagnostic cohort study (THYROPET). J Nucl Med, 57:701–707.
